By Annisa Sofia 
Istanbul, Turkey – May 14, 2024 – A groundbreaking study presented at the European Congress on Obesity (ECO) in Istanbul this week has unveiled significant sex-based disparities in how obesity impacts cardiovascular health, metabolic function, and inflammatory responses. The research, conducted by a team at Dokuz Eylul University in Turkey, offers critical insights that could pave the way for more personalized and effective obesity treatment strategies tailored to the unique biological profiles of men and women. The findings, presented during the congress held from May 12-15, underscore the urgent need for gender-specific approaches in tackling the global obesity epidemic.
Unpacking the Gender Divide in Obesity’s Health Consequences
The study, which analyzed data from 1,134 individuals (886 women and 248 men) treated at the Dokuz Eylul University Obesity Clinic, revealed distinct patterns of risk development. Researchers observed that men with obesity are more prone to accumulating visceral fat – the deep abdominal fat that encases vital organs and is a potent driver of cardiovascular disease and metabolic dysfunction. Concurrently, male participants exhibited elevated levels of liver enzymes, such as alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT), which can serve as indicators of potential liver damage.
In stark contrast, women with obesity demonstrated a greater propensity for systemic inflammation and higher cholesterol levels, particularly low-density lipoprotein (LDL) or "bad" cholesterol. These biomarkers are well-established contributors to an increased risk of heart disease and the development of type 2 diabetes. The study’s lead author, Dr. Zeynep Pekel of Dokuz Eylul University, emphasized the profound implications of these sex-specific findings.
"Our research illuminates crucial differences in how men and women experience and respond to obesity," Dr. Pekel stated. "This underscores the indispensable role of gender-specific research in understanding complex health conditions. Not only do biological sex differences significantly influence the pathology and progression of obesity, but our results strongly suggest that these distinctions can serve as a foundation for developing targeted, sex-based therapies to enhance the management of individuals living with obesity."
A Growing Global Health Crisis: Obesity and Metabolic Syndrome
The findings emerge against a backdrop of escalating global health challenges. In 2023, an estimated 1.54 billion adults worldwide were living with metabolic syndrome, a cluster of conditions that significantly elevate the risk of heart disease, stroke, and type 2 diabetes. This translates to approximately one in three women and one in four men. Metabolic syndrome is characterized by a constellation of risk factors including abdominal obesity, elevated blood pressure, high blood sugar levels, and abnormal cholesterol and triglyceride levels.
Obesity itself is recognized as a complex, chronic disease that affects the body through a multitude of pathways, including alterations in metabolism and inflammation. The variability in these physiological responses is substantial, and biological sex is a key determinant in these processes. Sex influences where fat is deposited, how the liver metabolizes nutrients, and the reactivity of the immune system. Despite this, comprehensive comparative studies detailing these sex-based differences in individuals with obesity have historically been limited.
Methodology: A Deep Dive into Sex-Based Obesity Markers
To meticulously investigate these sex-specific patterns, the Dokuz Eylul University research team collected and analyzed comprehensive data from 886 women, with an average age of 45 years, and 248 men, with an average age of 41 years. These participants were all receiving treatment at the Obesity Clinic within the Department of Internal Medicine at their university’s Faculty of Medicine, between January 2024 and January 2025.
The study employed a rigorous evaluation protocol. Standard anthropometric measurements were taken, including height, weight, body mass index (BMI), and blood pressure. Extensive blood analyses were conducted to assess cardiovascular risk factors. These included measurements of total cholesterol, LDL cholesterol (often referred to as "bad" cholesterol), high-density lipoprotein (HDL) cholesterol (the "good" cholesterol), triglycerides, and fasting blood glucose levels.
Furthermore, the research delved into specific biomarkers related to organ function and inflammation. Liver function was assessed through ALT and GGT levels, while kidney function was evaluated using creatinine levels. A panel of inflammatory markers was also examined, encompassing C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count, and platelet count. This multi-faceted approach aimed to provide a holistic understanding of the physiological impact of obesity across different sexes.
Key Findings: Divergent Fat Distribution and Biomarker Signatures
The quantitative analysis revealed several significant differences between the male and female cohorts. Men, on average, presented with a slightly higher BMI (37.5 kg/m²) compared to women (36 kg/m²). However, their waist circumference was notably larger (120 cm vs. 108 cm), and their systolic blood pressure was also elevated (128 mmHg vs. 122 mmHg). Both larger waist circumference and higher systolic blood pressure are recognized indicators of increased risk for cardiovascular disease and type 2 diabetes.
Men also exhibited statistically significant higher levels of liver enzymes (ALT and GGT), triglycerides, and creatinine. These elevated markers strongly suggest a greater predisposition to liver-related complications and metabolic disturbances among men with obesity.
Conversely, women in the study displayed higher levels of total cholesterol (215 mg/dL vs. 203 mg/dL) and LDL cholesterol (130 mg/dL vs. 123 mg/dL). Furthermore, they showed increased concentrations of several inflammatory markers, including ESR, CRP, and platelet count. These findings collectively point towards a more pronounced inflammatory response in women experiencing obesity.
Hormonal and Biological Underpinnings of Sex Differences
Dr. Pekel offered insights into the probable biological mechanisms driving these observed disparities. She posited that hormonal influences, the intricate workings of the immune system, and the patterns of fat distribution play pivotal roles. Hormones, particularly estrogen in women, are known to influence fat storage mechanisms and modulate the body’s inflammatory responses. Women characteristically tend to store more subcutaneous fat (fat beneath the skin), which is generally considered less metabolically harmful than visceral fat. Their inflammatory profiles, often reflected in higher levels of CRP and ESR, may also be linked to a generally more robust immune system activity, potentially influenced by genetic factors such as the presence of two X chromosomes.
In contrast, men are more inclined to accumulate visceral fat. This type of fat is metabolically active and strongly associated with the development of insulin resistance, dyslipidemia, and other metabolic derangements that heighten the risk of severe health complications.
The Road Ahead: Validation and Clinical Application
While the findings are compelling, Dr. Pekel acknowledged that the research is still in its early stages and requires further validation. "These results are preliminary and need to be confirmed in broader and more diverse patient populations," she cautioned. "However, they provide invaluable insight into the distinct ways obesity can manifest and impact men and women. The underlying differences are likely rooted in fundamental biological factors, including hormonal profiles, immune system dynamics, and fat distribution patterns."
The research team’s future plans involve conducting larger-scale studies to validate these findings and to gain a deeper understanding of the specific biological pathways involved. A key objective is to explore how these sex-based patterns directly correlate with clinical outcomes and long-term health risks. The ultimate goal is to translate these scientific discoveries into tangible improvements in clinical practice, leading to more effective and individualized care for patients struggling with obesity.
Addressing Study Limitations and Future Directions
The researchers were candid about the limitations of their study. As a cross-sectional analysis, it establishes associations but cannot definitively prove causation or rule out confounding variables or reverse causation. For instance, it is possible that pre-existing metabolic conditions might influence fat distribution or inflammatory markers, rather than vice-versa.
Another significant limitation is the demographic profile of the participants. The majority of individuals in the study were of Turkish ethnicity. This raises questions about the generalizability of the findings to other ethnic groups, who may exhibit different genetic predispositions and environmental influences that affect obesity and its associated health risks. Therefore, the researchers stressed the necessity of conducting larger, more diverse studies to confirm and expand upon these initial results, ensuring that the insights are broadly applicable.
The European Congress on Obesity (ECO) serves as a vital platform for disseminating the latest research and fostering collaboration among leading experts in the field. The congress typically convenes annually, bringing together scientists, clinicians, policymakers, and patient advocates to discuss advancements, challenges, and future directions in obesity research and management. This year’s event in Istanbul, a vibrant hub bridging Europe and Asia, provided a timely setting for the presentation of these critical sex-specific findings, reinforcing the congress’s commitment to advancing the understanding and treatment of obesity on a global scale.
The implications of this research are far-reaching. By recognizing and understanding the distinct physiological responses to obesity in men and women, healthcare providers can move beyond a one-size-fits-all approach. This could involve tailoring dietary recommendations, exercise regimens, and pharmacological interventions based on an individual’s sex and the specific metabolic and inflammatory profiles identified. For instance, treatments that target inflammation might be prioritized for women, while strategies aimed at reducing visceral fat accumulation could be emphasized for men. Such personalized medicine approaches hold the promise of improving treatment efficacy, enhancing patient adherence, and ultimately leading to better long-term health outcomes in the fight against the pervasive and complex disease of obesity.